BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Micheu MM, Dorobantu M. Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction. World J Stem Cells 2017; 9(4): 68-76 [PMID: 28491241 DOI: 10.4252/wjsc.v9.i4.68]
URL: https://www.wjgnet.com/1948-0210/full/v9/i4/68.htm
Number Citing Articles
1
Alireza Hosseinpour, Fatemeh Kheshti, Asma Kazemi, Armin Attar. Comparing the effect of bone marrow mono-nuclear cells with mesenchymal stem cells after acute myocardial infarction on improvement of left ventricular function: a meta-analysis of clinical trialsStem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02883-3
2
Martina Colicchia, Daniel A. Jones, Anne-Marie Beirne, Mohsin Hussain, Deshan Weeraman, Krishnaraj Rathod, Jessry Veerapen, Mark Lowdell, Anthony Mathur. Umbilical cord–derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical dataCytotherapy 2019; 21(10): 1007 doi: 10.1016/j.jcyt.2019.04.056
3
Maria Dorobantu, Nicoleta-Monica Popa-Fotea, Mihaela Popa, Iulia Rusu, Miruna Mihaela Micheu. Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac diseaseWorld Journal of Stem Cells 2017; 9(12): 203-218 doi: 10.4252/wjsc.v9.i12.203
4
Miruna Mihaela Micheu, Alina Ioana Scarlatescu, Alexandru Scafa-Udriste, Maria Dorobantu. The Winding Road of Cardiac Regeneration—Stem Cell Omics in the SpotlightCells 2018; 7(12): 255 doi: 10.3390/cells7120255
5
Yuka Okinaka, Akie Kikuchi-Taura, Yukiko Takeuchi, Yuko Ogawa, Johannes Boltze, Sheraz Gul, Carsten Claussen, Akihiko Taguchi. Clot-Derived Contaminants in Transplanted Bone Marrow Mononuclear Cells Impair the Therapeutic Effect in StrokeStroke 2019; 50(10): 2883 doi: 10.1161/STROKEAHA.119.026669
6
Mariah Madigan, Rony Atoui. Therapeutic Use of Stem Cells for Myocardial InfarctionBioengineering 2018; 5(2): 28 doi: 10.3390/bioengineering5020028
7
Philippe Menasché. Cardiac cell therapy: Current status, challenges and perspectivesArchives of Cardiovascular Diseases 2020; 113(4): 285 doi: 10.1016/j.acvd.2020.01.002
8
Miruna Mihaela Micheu. Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure – time for new recommendations?World Journal of Stem Cells 2019; 11(8): 445-451 doi: 10.4252/wjsc.v11.i8.445
9
Gabriela Maciel Lopes, Patrícia Bencke Grudzinski, Nance Beyer Nardi, Natalia Motta Leguisamo. Cell Therapy Improves Cardiac Function in Anthracycline-Induced Cardiomyopathy Preclinical Models: A Systematic Review and Meta-AnalysisStem Cells and Development 2020; 29(19): 1247 doi: 10.1089/scd.2020.0044
10
Anthony Mathur, Doo Sun Sim, Fizzah Choudry, Jessry Veerapen, Martina Colicchia, Tymoteusz Turlejski, Mohsin Hussain, Stephen Hamshere, Didier Locca, Roby Rakhit, Tom Crake, Jens Kastrup, Samir Agrawal, Daniel A. Jones, John Martin. Five‐year follow‐up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE‐AMI trialESC Heart Failure 2022; 9(2): 1152 doi: 10.1002/ehf2.13786
11
Stephen E. Epstein, Michael J. Lipinski, Dror Luger. Persistent Inflammation, Stem Cell–Induced Systemic Anti‐Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart FailureJournal of the American Heart Association 2018; 7(4) doi: 10.1161/JAHA.118.008524